Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
10x Genomics, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $877.40M | $857.97M - $892.87M | -$179.40M | -$0.13 | 5 |
| Dec 2029 | $790.23M | $772.73M - $804.16M | -$161.57M | -$0.333 | 5 |
| Dec 2028 | $715.86M | $715.71M - $716.01M | -$146.37M | -$0.451 | 10 |
| Dec 2027 | $664.89M | $649.49M - $681.32M | -$135.95M | -$0.641 | 12 |
| Dec 2026 | $613.23M | $603.19M - $617.70M | -$125.38M | -$0.761 | 12 |
| Dec 2025 | $636.44M | $622.35M - $647.66M | -$130.13M | -$0.426 | 4 |
| Dec 2024 | $605.23M | $599.12M - $612.11M | -$123.75M | -$1.413 | 7 |
| Dec 2023 | $631.73M | $617.75M - $642.87M | -$129.17M | -$2.018 | 6 |
| Dec 2022 | $508.11M | $501.50M - $514.46M | -$54.22M | -$1.622 | 6 |
| Dec 2021 | $493.74M | $487.32M - $499.92M | -$26.38M | -$0.463 | 7 |
| Dec 2020 | $286.92M | $283.19M - $290.51M | -$5.49B | -$1.472 | 7 |
| Dec 2019 | $240.57M | $237.45M - $243.58M | -$89.00M | -$0.614 | 6 |